Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 18;14(4):e0214121.
doi: 10.1371/journal.pone.0214121. eCollection 2019.

Artificial intelligence and the analysis of multi-platform metabolomics data for the detection of intrauterine growth restriction

Affiliations

Artificial intelligence and the analysis of multi-platform metabolomics data for the detection of intrauterine growth restriction

Ray Oliver Bahado-Singh et al. PLoS One. .

Abstract

Objective: To interrogate the pathogenesis of intrauterine growth restriction (IUGR) and apply Artificial Intelligence (AI) techniques to multi-platform i.e. nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) based metabolomic analysis for the prediction of IUGR.

Materials and methods: MS and NMR based metabolomic analysis were performed on cord blood serum from 40 IUGR (birth weight < 10th percentile) cases and 40 controls. Three variable selection algorithms namely: Correlation-based feature selection (CFS), Partial least squares regression (PLS) and Learning Vector Quantization (LVQ) were tested for their diagnostic performance. For each selected set of metabolites and the panel consists of metabolites common in three selection algorithms so-called overlapping set (OL), support vector machine (SVM) models were developed for which parameter selection was performed busing 10-fold cross validations. Area under the receiver operating characteristics curve (AUC), sensitivity and specificity values were calculated for IUGR diagnosis. Metabolite set enrichment analysis (MSEA) was performed to identify which metabolic pathways were perturbed as a direct result of IUGR in cord blood serum.

Results: All selected metabolites and their overlapping set achieved statistically significant accuracies in the range of 0.78-0.82 for their optimized SVM models. The model utilizing all metabolites in the dataset had an AUC = 0.91 with a sensitivity of 0.83 and specificity equal to 0.80. CFS and OL (Creatinine, C2, C4, lysoPC.a.C16.1, lysoPC.a.C20.3, lysoPC.a.C28.1, PC.aa.C24.0) showed the highest performance with sensitivity (0.87) and specificity (0.87), respectively. MSEA revealed significantly altered metabolic pathways in IUGR cases. Dysregulated pathways include: beta oxidation of very long fatty acids, oxidation of branched chain fatty acids, phospholipid biosynthesis, lysine degradation, urea cycle and fatty acid metabolism.

Conclusion: A systematically selected panel of metabolites was shown to accurately detect IUGR in newborn cord blood serum. Significant disturbance of hepatic function and energy generating pathways were found in IUGR cases.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Study design from data preprocessing through performance evaluation.
Fig 2
Fig 2
A) ROC with AUC values, B) permutation test obtained from the OL set.
Fig 3
Fig 3. Performance evaluation in terms of sensitivity, specificity, and AUC for all metabolite panels obtained different variable selection algorithms.
Fig 4
Fig 4. Bar graph: altered pathways in enrichment analysis showing top fifteen metabolic pathways perturbed upon IUGR.

References

    1. ACOG Practice bulletin no. 134: fetal growth restriction. Obstetrics and gynecology. 2013;121(5):1122–33. Epub 2013/05/03. 10.1097/01.AOG.0000429658.85846.f9 . - DOI - PubMed
    1. Resnik R. Intrauterine growth restriction. Obstet Gynecol. 2002;99(3):490–6. Epub 2002/02/28. . - PubMed
    1. Pallotto EK, Kilbride HW. Perinatal outcome and later implications of intrauterine growth restriction. Clinical obstetrics and gynecology. 2006;49(2):257–69. Epub 2006/05/25. . - PubMed
    1. Favretto D, Cosmi E, Ragazzi E, Visentin S, Tucci M, Fais P, et al. Cord blood metabolomic profiling in intrauterine growth restriction. Analytical and bioanalytical chemistry. 2012;402(3):1109–21. Epub 2011/11/22. 10.1007/s00216-011-5540-z . - DOI - PubMed
    1. Dessì A, Ottonello G, Fanos V. Physiopathology of intrauterine growth retardation: from classic data to metabolomics. The Journal of Maternal-Fetal & Neonatal Medicine. 2012;25(sup5):13–8. 10.3109/14767058.2012.714639 - DOI - PubMed